Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03448016 · ClinicalTrials.gov registry record · Early Phase 1
[C-11]NOP-1A and Alcohol Use Disorder
A Early Phase 1 study, sponsored by Rajesh Narendran.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 54
- Enrollment target
NCT03448016: Completed Early Phase 1 study, sponsored by Rajesh Narendran.
NCT03448016 is a Early Phase 1 study that has completed, run by Rajesh Narendran. The registered enrollment target is 54 participants, roughly in line with the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03448016, a Early Phase 1 study, has completed, sponsored by Rajesh Narendran.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 54 participants
- Enrollment target
Study Summary
The goal of this study is to compare \[C-11\]NOP-1A binding in recently abstinent alcohol use disorders and controls
Primary Outcome
VT-Volume of distribution expressed relative to total plasma
Interventions
- RADIATION [C-11]
- DRUG NOP-1A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2016-05-27 |
| Est. Completion | 2021-03-30 |
| Phase | Early Phase 1 |
What the finished NCT03448016 record still lists
NCT03448016 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 54 participants, a relatively small participant target, roughly in line with the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target.
The record links to 0 conditions, and to 2 interventions - of which [C-11] is the first listed.
NCT03448016 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03448016 about?
NCT03448016 is a clinical study titled "[C-11]NOP-1A and Alcohol Use Disorder". The goal of this study is to compare \[C-11\]NOP-1A binding in recently abstinent alcohol use disorders and controls
What is the current status of trial NCT03448016?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 54 participants. The study started on 2016-05-27. Estimated completion is 2021-03-30.
What interventions are being tested in trial NCT03448016?
The interventions under investigation include: [C-11] (RADIATION), NOP-1A (DRUG).
Who is sponsoring clinical trial NCT03448016?
This trial is sponsored by Rajesh Narendran, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03448016's enrollment target sits among peer trials
54 464th of 2000 higher than 1,530 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI